Cephalon uses Fentora patent disclosures to claim Watson’s generic has unapproved active
18 March 2011
Nancy Faigen
Please Login to read the full article.
18 March 2011
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Generic Provigil hits US market, but Mylan sues over an FDA 180-day exclusivity ruling
- SCOTUS takes on tax/penalty issue in opening health reform arguments
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
